BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 25124476)

  • 1. Recent insights into the biology of neuroblastoma.
    Schleiermacher G; Janoueix-Lerosey I; Delattre O
    Int J Cancer; 2014 Nov; 135(10):2249-61. PubMed ID: 25124476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular pathogenesis of peripheral neuroblastic tumors.
    Janoueix-Lerosey I; Schleiermacher G; Delattre O
    Oncogene; 2010 Mar; 29(11):1566-79. PubMed ID: 20101209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline gain-of-function mutations of ALK disrupt central nervous system development.
    de Pontual L; Kettaneh D; Gordon CT; Oufadem M; Boddaert N; Lees M; Balu L; Lachassinne E; Petros A; Mollet J; Wilson LC; Munnich A; Brugière L; Delattre O; Vekemans M; Etchevers H; Lyonnet S; Janoueix-Lerosey I; Amiel J
    Hum Mutat; 2011 Mar; 32(3):272-6. PubMed ID: 21972109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global genomic and RNA profiles for novel risk stratification of neuroblastoma.
    Ohira M; Nakagawara A
    Cancer Sci; 2010 Nov; 101(11):2295-301. PubMed ID: 20731666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics and genomics of neuroblastoma.
    Capasso M; Diskin SJ
    Cancer Treat Res; 2010; 155():65-84. PubMed ID: 20517688
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic and germline activating mutations of the ALK kinase receptor in neuroblastoma.
    Janoueix-Lerosey I; Lequin D; Brugières L; Ribeiro A; de Pontual L; Combaret V; Raynal V; Puisieux A; Schleiermacher G; Pierron G; Valteau-Couanet D; Frebourg T; Michon J; Lyonnet S; Amiel J; Delattre O
    Nature; 2008 Oct; 455(7215):967-70. PubMed ID: 18923523
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic predisposition and chromosome instability in neuroblastoma.
    Tonini GP; Capasso M
    Cancer Metastasis Rev; 2020 Mar; 39(1):275-285. PubMed ID: 31927719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative pathways of MYCN gene copy number increase in primary neuroblastoma tumors.
    Valent A; Guillaud-Bataille M; Farra C; Lozach F; Spengler B; Terrier-Lacombe MJ; Valteau-Couanet D; Danglot G; Lenoir GM; Brison O; Bénard J; Bernheim A
    Cancer Genet Cytogenet; 2004 Aug; 153(1):10-5. PubMed ID: 15325088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New insights into the genetic basis of neuroblastoma].
    Speleman F; De Preter K; Hoebeeck J; Van Roy N; Vandesompele J
    Verh K Acad Geneeskd Belg; 2007; 69(4):167-96. PubMed ID: 17821957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nervous system: Embryonal tumors: Neuroblastoma.
    Pudela C; Balyasny S; Applebaum MA
    Atlas Genet Cytogenet Oncol Haematol; 2020 Jul; 24(7):284-290. PubMed ID: 32296467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic susceptibility to neuroblastoma.
    Tolbert VP; Coggins GE; Maris JM
    Curr Opin Genet Dev; 2017 Feb; 42():81-90. PubMed ID: 28458126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroblastoma: paradigm for precision medicine.
    Irwin MS; Park JR
    Pediatr Clin North Am; 2015 Feb; 62(1):225-56. PubMed ID: 25435121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PHOX2B mutations and genetic predisposition to neuroblastoma.
    Perri P; Bachetti T; Longo L; Matera I; Seri M; Tonini GP; Ceccherini I
    Oncogene; 2005 Apr; 24(18):3050-3. PubMed ID: 15735672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Genetic alterations in neuroblastoma and their usefulness for clinical management].
    Normand C; Michon J; Janoueix-Lerosey I; Delattre O; Schleiermacher G
    Bull Cancer; 2011 May; 98(5):477-88. PubMed ID: 21609891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in the understanding of constitutional and somatic genomic alterations in neuroblastoma.
    Deyell RJ; Attiyeh EF
    Cancer Genet; 2011 Mar; 204(3):113-21. PubMed ID: 21504710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroblastoma and Its Zebrafish Model.
    Zhu S; Thomas Look A
    Adv Exp Med Biol; 2016; 916():451-78. PubMed ID: 27165366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic susceptibility to neuroblastoma: current knowledge and future directions.
    Ritenour LE; Randall MP; Bosse KR; Diskin SJ
    Cell Tissue Res; 2018 May; 372(2):287-307. PubMed ID: 29589100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oligogenic inheritance in neuroblastoma.
    Longo L; Tonini GP; Ceccherini I; Perri P
    Cancer Lett; 2005 Oct; 228(1-2):65-9. PubMed ID: 15923081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylation-associated PHOX2B gene silencing is a rare event in human neuroblastoma.
    de Pontual L; Trochet D; Bourdeaut F; Thomas S; Etchevers H; Chompret A; Minard V; Valteau D; Brugieres L; Munnich A; Delattre O; Lyonnet S; Janoueix-Lerosey I; Amiel J
    Eur J Cancer; 2007 Nov; 43(16):2366-72. PubMed ID: 17765533
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-resolution array CGH profiling identifies Na/K transporting ATPase interacting 2 (NKAIN2) as a predisposing candidate gene in neuroblastoma.
    Romania P; Castellano A; Surace C; Citti A; De Ioris MA; Sirleto P; De Mariano M; Longo L; Boldrini R; Angioni A; Locatelli F; Fruci D
    PLoS One; 2013; 8(10):e78481. PubMed ID: 24205241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.